Src, IGFR1R and FAK, which are also implicated in proliferation pathways, have been demonstrated to be enriched in prostate cancer EVs [55], suggesting that Evs are disseminators of the molecular drivers of cellular proliferation. Here, PTK2 is linked to prostate carcinoma.